☰

Rhoda Alani - Publications

Affiliations: 
Johns Hopkins University, Baltimore, MD 
Area:
Molecular Biology, Cell Biology
Tree Info Grants Similar researchers PubMed Report error

32 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2024 Waddell A, Grbic N, Leibowitz K, Wyant WA, Choudhury S, Park K, Collard M, Cole PA, Alani RM. p300 KAT regulates SOX10 stability and function in human melanoma. Biorxiv : the Preprint Server For Biology. PMID 38469149 DOI: 10.1101/2024.02.20.581224  0.447
2020 Hanly A, Gibson F, Kuang K, Kim E, Zucconi BE, Wu M, Cole P, Alani R. 692 Using a novel p300 HAT inhibitor as epigenetic therapy to treat BRAF inhibitor-resistant melanoma cells Journal of Investigative Dermatology. 140. DOI: 10.1016/J.Jid.2020.03.704  0.321
2019 Anastas JN, Zee BM, Kalin JH, Kim M, Guo R, Alexandrescu S, Blanco MA, Giera S, Gillespie SM, Das J, Wu M, Nocco S, Bonal DM, Nguyen QD, Suva ML, ... ... Alani R, et al. Re-programing Chromatin with a Bifunctional LSD1/HDAC Inhibitor Induces Therapeutic Differentiation in DIPG. Cancer Cell. PMID 31631026 DOI: 10.1016/J.Ccell.2019.09.005  0.354
2019 Kim E, Zucconi BE, Wu M, Nocco SE, Meyers DJ, McGee JS, Venkatesh S, Cohen DL, Gonzalez EC, Ryu B, Cole PA, Alani RM. MITF Expression Predicts Therapeutic Vulnerability to p300 Inhibition in Human Melanoma. Cancer Research. PMID 30910803 DOI: 10.1158/0008-5472.Can-18-2331  0.304
2019 Kida M, Falanga V, Wu M, Cole P, Kalin J, Alani R. 941 Epigenetic manipulation of epidermal cells leads to enhanced cellular migration without an increase in cell proliferation Journal of Investigative Dermatology. 139: S162. DOI: 10.1016/J.Jid.2019.03.1017  0.358
2018 Eisenstein A, Gonzalez EC, Raghunathan R, Xu X, Wu M, McLean EO, McGee J, Ryu B, Alani RM. Emerging Biomarkers in Cutaneous Melanoma. Molecular Diagnosis & Therapy. PMID 29411301 DOI: 10.1007/S40291-018-0318-Z  0.312
2017 Hsu MY, Yang MH, Schnegg CI, Hwang S, Ryu B, Alani RM. Notch3 signaling-mediated melanoma-endothelial crosstalk regulates melanoma stem-like cell homeostasis and niche morphogenesis. Laboratory Investigation; a Journal of Technical Methods and Pathology. PMID 28165469 DOI: 10.1038/Labinvest.2017.1  0.388
2017 Wu M, Kalin J, Ryu B, Cole P, Alani R. Abstract 5068: A novel dual action inhibitor of histone deacetylase and demethylase in melanoma Cancer Research. 77: 5068-5068. DOI: 10.1158/1538-7445.Am2017-5068  0.435
2016 Moriarty WF, Kim E, Gerber SA, Hammers H, Alani RM. Neuropilin-2 promotes melanoma growth and progression in vivo. Melanoma Research. PMID 26881875 DOI: 10.1097/Cmr.0000000000000190  0.813
2016 Moriarty WF, Kim E, Gerber SA, Hammers H, Alani RM. Neuropilin-2 promotes melanoma growth and progression in vivo Melanoma Research. DOI: 10.1097/CMR.0000000000000190  0.767
2015 Zhang C, Shenk EM, Blaha LC, Ryu B, Alani RM, Cabodi M, Wong JY. A simple engineered platform reveals different modes of tumor-microenvironmental cell interaction. Biofabrication. 8: 015001. PMID 26716792 DOI: 10.1088/1758-5090/8/1/015001  0.308
2015 Blaha L, Zhang C, Ryu B, Alani R, Cabodi M, Wong J. Abstract B11: A microfluidic platform to evaluate soluble signaling in the metastasis microenvironment Cancer Research. 75. DOI: 10.1158/1538-7445.Chtme14-B11  0.388
2014 Rossi M, Tuck J, Kim OJ, Panova I, Symanowski JT, Mahalingam M, Riker AI, Alani RM, Ryu B. Neuropilin-2 gene expression correlates with malignant progression in cutaneous melanoma. The British Journal of Dermatology. 171: 403-8. PMID 24359286 DOI: 10.1111/bjd.12801  0.37
2013 Howard JD, Moriarty WF, Park J, Riedy K, Panova IP, Chung CH, Suh KY, Levchenko A, Alani RM. Notch signaling mediates melanoma-endothelial cell communication and melanoma cell migration. Pigment Cell & Melanoma Research. 26: 697-707. PMID 23773728 DOI: 10.1111/Pcmr.12131  0.794
2013 Yan G, Eller MS, Elm C, Larocca CA, Ryu B, Panova IP, Dancy BM, Bowers EM, Meyers D, Lareau L, Cole PA, Taverna SD, Alani RM. Selective inhibition of p300 HAT blocks cell cycle progression, induces cellular senescence, and inhibits the DNA damage response in melanoma cells. The Journal of Investigative Dermatology. 133: 2444-52. PMID 23698071 DOI: 10.1038/Jid.2013.187  0.349
2012 Rushing EC, Stine MJ, Hahn SJ, Shea S, Eller MS, Naif A, Khanna S, Westra WH, Jungbluth AA, Busam KJ, Mahalingam M, Alani RM. Neuropilin-2: a novel biomarker for malignant melanoma? Human Pathology. 43: 381-9. PMID 21840568 DOI: 10.1016/j.humpath.2011.05.008  0.4
2011 Zigler M, Villares GJ, Dobroff AS, Wang H, Huang L, Braeuer RR, Kamiya T, Melnikova VO, Song R, Friedman R, Alani RM, Bar-Eli M. Expression of Id-1 is regulated by MCAM/MUC18: a missing link in melanoma progression. Cancer Research. 71: 3494-504. PMID 21467165 DOI: 10.1158/0008-5472.Can-10-3555  0.352
2011 Ryu B, Moriarty WF, Stine MJ, DeLuca A, Kim DS, Meeker AK, Grills LD, Switzer RA, Eller MS, Alani RM. Global analysis of BRAFV600E target genes in human melanocytes identifies matrix metalloproteinase-1 as a critical mediator of melanoma growth. The Journal of Investigative Dermatology. 131: 1579-83. PMID 21451543 DOI: 10.1038/Jid.2011.65  0.762
2011 Stine MJ, Wang CJ, Moriarty WF, Ryu B, Cheong R, Westra WH, Levchenko A, Alani RM. Integration of genotypic and phenotypic screening reveals molecular mediators of melanoma-stromal interaction. Cancer Research. 71: 2433-44. PMID 21324919 DOI: 10.1158/0008-5472.Can-10-1875  0.787
2010 Bhattacharya R, Kowalski J, Larson AR, Brock M, Alani RM. Id1 promotes tumor cell migration in nonsmall cell lung cancers. Journal of Oncology. 2010: 856105. PMID 20414347 DOI: 10.1155/2010/856105  0.31
2010 Silverthorn CF, Alani RM. Glyceraldehyde-3-phosphate dehydrogenase expression is altered by hypoxia in melanoma cells and primary human melanocytes. Melanoma Research. 20: 61-3. PMID 20051782 DOI: 10.1097/Cmr.0B013E328333D8C2  0.718
2009 Larson AR, Konat E, Alani RM. Melanoma biomarkers: current status and vision for the future. Nature Clinical Practice. Oncology. 6: 105-17. PMID 19107110 DOI: 10.1038/ncponc1296  0.336
2008 DeLuca AM, Srinivas A, Alani RM. BRAF kinase in melanoma development and progression. Expert Reviews in Molecular Medicine. 10: e6. PMID 18279546 DOI: 10.1017/S1462399408000604  0.348
2008 Cummings SD, Ryu B, Samuels MA, Yu X, Meeker AK, Healey MA, Alani RM. Id1 delays senescence of primary human melanocytes. Molecular Carcinogenesis. 47: 653-9. PMID 18240291 DOI: 10.1002/Mc.20422  0.775
2007 Ryu B, Kim DS, Deluca AM, Alani RM. Comprehensive expression profiling of tumor cell lines identifies molecular signatures of melanoma progression. Plos One. 2: e594. PMID 17611626 DOI: 10.1371/journal.pone.0000594  0.428
2007 Ryu B, Kim DS, DeLuca AM, Healey MA, Dunlap S, Fackler MJ, Herman J, Alani RM. Id1 expression is transcriptionally regulated in radial growth phase melanomas. International Journal of Cancer. Journal International Du Cancer. 121: 1705-9. PMID 17565736 DOI: 10.1002/ijc.22875  0.415
2007 Fecher LA, Cummings SD, Keefe MJ, Alani RM. Toward a molecular classification of melanoma. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 25: 1606-20. PMID 17443002 DOI: 10.1200/Jco.2006.06.0442  0.665
2006 Cummings S, Ryu B, Alani R. Defining the role of Id-1 in melanoma development and progression Melanoma Research. 16: S77. DOI: 10.1097/00008390-200609001-00139  0.765
2005 Govindarajan B, Shah A, Cohen C, Arnold RS, Schechner J, Chung J, Mercurio AM, Alani R, Ryu B, Fan CY, Cuezva JM, Martinez M, Arbiser JL. Malignant transformation of human cells by constitutive expression of platelet-derived growth factor-BB. The Journal of Biological Chemistry. 280: 13936-43. PMID 15695519 DOI: 10.1074/Jbc.M500411200  0.456
2004 Alani RM, Silverthorn CF, Orosz K. Tumor angiogenesis in mice and men. Cancer Biology & Therapy. 3: 498-500. PMID 15153806 DOI: 10.4161/Cbt.3.6.930  0.722
2003 Sikder H, Huso DL, Zhang H, Wang B, Ryu B, Hwang ST, Powell JD, Alani RM. Disruption of Id1 reveals major differences in angiogenesis between transplanted and autochthonous tumors. Cancer Cell. 4: 291-9. PMID 14585356  0.346
1997 Arbiser JL, Alani R, Flynn E, Wooten V, Byers HR. Effects of thallium ion on cellular components of the skin. The Journal of Dermatology. 24: 147-55. PMID 9114610 DOI: 10.1111/J.1346-8138.1997.Tb02762.X  0.33
Show low-probability matches.